Lantheus Holdings (LNTH) Accumulated Expenses (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Accumulated Expenses came in at $286.5 million in Q1 2026, up 41.56% year-on-year from $202.4 million in Q1 2025, and up 7.18% on a QoQ basis from $267.3 million in Q4 2025.

Lantheus Holdings (LNTH) Accumulated Expenses (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Accumulated Expenses data on file, last reported at $286.5 million in Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 41.56% year-over-year to $286.5 million in Q1 2026; TTM through Mar 2026 was $286.5 million, a 41.56% increase from a year earlier, with the FY2025 full-year figure at $267.3 million, up 453.85% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $286.5 million, up from $267.3 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for LNTH reached as high as $286.5 million in Q1 2026 and fell as low as $48.3 million in Q4 2024.
  • Historically, Accumulated Expenses has averaged $178.7 million across 5 years, with a median of $183.8 million in 2022.
  • Across the five-year window, Accumulated Expenses plunged 66.79% in 2024 and jumped 453.85% in 2025, its largest moves.
  • Year by year, Accumulated Expenses stood at $127.1 million in 2022, then rose by 14.36% to $145.3 million in 2023, then slumped by 66.79% to $48.3 million in 2024, then soared by 453.85% to $267.3 million in 2025, then grew by 7.18% to $286.5 million in 2026.
  • Per Business Quant data, the three most recent Accumulated Expenses figures were $286.5 million in Q1 2026, $267.3 million in Q4 2025, and $251.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 286.49 Mn
Dec 31, 2025 267.31 Mn
Sep 30, 2025 251.11 Mn
Jun 30, 2025 208.60 Mn
Mar 31, 2025 202.38 Mn
Dec 31, 2024 48.26 Mn
Sep 30, 2024 174.45 Mn
Jun 30, 2024 212.64 Mn
Mar 31, 2024 198.94 Mn
Dec 31, 2023 145.34 Mn
Sep 30, 2023 138.82 Mn
Jun 30, 2023 114.80 Mn
Mar 31, 2023 145.47 Mn
Dec 31, 2022 127.08 Mn
Sep 30, 2022 190.48 Mn
Jun 30, 2022 183.80 Mn
Mar 31, 2022 142.40 Mn
Dec 31, 2021 58.07 Mn
Sep 30, 2021 46.04 Mn
Jun 30, 2021 41.98 Mn